Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcichew D3 formulation preference and acceptability crossover study
2014-005619-18Phase 4Completed
- Sponsor
- Takeda
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of calcium carbonate + cholecalciferol in Vitamin D deficiency (VDD), hypocalcemia and osteoporosis (4 arms), sponsored by Takeda. Primary endpoint: Treatment preference within each test group. Started Mar 2015; status: completed.
02
Drugs
calcium carbonate + cholecalciferol
03
Conditions
Vitamin D deficiency (VDD)hypocalcemiaosteoporosis
Beyond the preview
Go deeper on 2014-005619-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005619-18.